F, B., M, B., R, H., R, C., C, S., R, U., . . . C, H. (2026). CAR T-Cell Therapy in Patients With Primary Central Nervous System Lymphoma: A LOC Network Study. American journal of hematology, 101(8), 2069. https://doi.org/10.1002/ajh.70375
Chicago Style (17th ed.) CitationF, Bouille, et al. "CAR T-Cell Therapy in Patients With Primary Central Nervous System Lymphoma: A LOC Network Study." American Journal of Hematology 101, no. 8 (2026): 2069. https://doi.org/10.1002/ajh.70375.
MLA (9th ed.) CitationF, Bouille, et al. "CAR T-Cell Therapy in Patients With Primary Central Nervous System Lymphoma: A LOC Network Study." American Journal of Hematology, vol. 101, no. 8, 2026, p. 2069, https://doi.org/10.1002/ajh.70375.
Warning: These citations may not always be 100% accurate.